Olivier Zava
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Olivier Zava has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
- Paul Joseph Dyson
Institute of Chemical Sciences and Engineering Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne Switzerland
28 shared publications - Bruno Therrien
Institute of Chemistry, University of Neuchatel, Ave de Bellevaux 51, CH-2000 Neuchatel, Switzerland
16 shared publications - Nicolas P. E. Barry
School of Chemistry and Biosciences University of Bradford Bradford BD7 1DP UK
8 shared publications - Alexey A. Nazarov
Department of Chemistry, M.V. Lomonosov Moscow State University, 1/3 Leninskie Gory, 119991 Moscow, Russia
7 shared publications - Angela Casini
Chair of Medicinal and Bioinorganic Chemistry, School of Natural Sciences, Department of Chemistry, Technical University of Munich, Lichtenbergstr. 4, D-85748 Garching b. München, Germany
6 shared publications - Michael Groessl
Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland
5 shared publications
Latest Publications
- Open Access
- 13 December 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (1) , 116-126
Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment
By screening a drug library comprising FDA approved compounds, we discovered a potent interaction between the antifungal agent haloprogin and the experimental organometallic drug RAPTA-T, to synergistically induce cancer cell killing. The combination of these two small molecules, even at low doses, elicited an improved therapeutic response on tumor growth over either agent alone or the current treatment used in the clinic in the highly aggressive syngeneic B16F10 melanoma tumor model, where classical cytotoxic chemotherapeutic agents show little efficacy. The combination with the repurposed chemodrug haloprogin provides the basis for a new powerful treatment option for cutaneous melanoma. Importantly, because synergistic induction of tumor cell death is achieved with low individual drug doses, and cellular targets for RAPTA-T are different from those of classical chemotherapeutic drugs, a therapeutic strategy based on this approach could avoid toxicities and potentially resistance mechanisms, and could even inhibit metastatic progression.
- 13 December 2017
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 15 (1) , 116-126
Open AccessDrug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment
By screening a drug library comprising FDA approved compounds, we discovered a potent interaction between the antifungal agent haloprogin and the experimental organometallic drug RAPTA-T, to synergistically induce cancer cell killing. The combination of these two small molecules, even at low doses, elicited an improved therapeutic response on tumor growth over either agent alone or the current treatment used in the clinic in the highly aggressive syngeneic B16F10 melanoma tumor model, where classical cytotoxic chemotherapeutic agents show little efficacy. The combination with the repurposed chemodrug haloprogin provides the basis for a new powerful treatment option for cutaneous melanoma. Importantly, because synergistic induction of tumor cell death is achieved with low individual drug doses, and cellular targets for RAPTA-T are different from those of classical chemotherapeutic drugs, a therapeutic strategy based on this approach could avoid toxicities and potentially resistance mechanisms, and could even inhibit metastatic progression.
- Open Access
- 30 October 2014
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 44 (8) , 3614-3623
Protein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity
The conjugation of chlorambucil to the RAPTA scaffold results in an anticancer active agent capable of cross-linking DNA and proteins.
- 30 October 2014
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 44 (8) , 3614-3623
Open AccessProtein ruthenation and DNA alkylation: chlorambucil-functionalized RAPTA complexes and their anticancer activity
The conjugation of chlorambucil to the RAPTA scaffold results in an anticancer active agent capable of cross-linking DNA and proteins.
- 1 April 2013
- Published by Elsevier in Journal of Organometallic Chemistry
- Vol. 730, 49-56
Arene ruthenium dichloro complexes containing isonicotinic ester ligands: Synthesis, molecular structure and cytotoxicity
- 1 April 2013
- Published by Elsevier in Journal of Organometallic Chemistry
- Vol. 730, 49-56
Arene ruthenium dichloro complexes containing isonicotinic ester ligands: Synthesis, molecular structure and cytotoxicity
- Open Access
- 19 March 2013
- Published by Springer Nature in Scientific Reports
- Vol. 3 (1) , srep01485
Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
New triruthenium-carbonyl clusters derivatized with glucose-modified bicyclophosphite ligands have been synthesized. These compounds were found to have cytostatic and cytotoxic activity and depending on the number of bicyclophosphite ligands, and could be tuned for either anti-cancer or specific anti-angiogenic activity. While some compounds had a broad cellular toxicity profile in several cell types others showed endothelial cell specific dose-dependent anti-proliferative and anti-migratory efficacy. A profound inhibition of angiogenesis was also observed in the in vivo chicken chorioallantoic membrane (CAM) model, and consequently, these new compounds have considerable potential in drug design, e.g. for the treatment of cancer.
- 19 March 2013
- Published by Springer Nature in Scientific Reports
- Vol. 3 (1) , srep01485
Open AccessSynthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters
New triruthenium-carbonyl clusters derivatized with glucose-modified bicyclophosphite ligands have been synthesized. These compounds were found to have cytostatic and cytotoxic activity and depending on the number of bicyclophosphite ligands, and could be tuned for either anti-cancer or specific anti-angiogenic activity. While some compounds had a broad cellular toxicity profile in several cell types others showed endothelial cell specific dose-dependent anti-proliferative and anti-migratory efficacy. A profound inhibition of angiogenesis was also observed in the in vivo chicken chorioallantoic membrane (CAM) model, and consequently, these new compounds have considerable potential in drug design, e.g. for the treatment of cancer.
- 21 November 2012
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 42 (17) , 6102-6109
BODIPY–phosphane as a versatile tool for easy access to new metal-based theranostics
A new BODIPY–phosphane was synthesized and proved to be a versatile tool for imaging organometallic complexes. It also led to easy access to a new family of theranostics, featuring gold, ruthenium and osmium complexes. The compounds’ cytotoxicity was tested on cancer cells, and their cell uptake was followed by fluorescence microscopy in vitro.
- 21 November 2012
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 42 (17) , 6102-6109
BODIPY–phosphane as a versatile tool for easy access to new metal-based theranostics
A new BODIPY–phosphane was synthesized and proved to be a versatile tool for imaging organometallic complexes. It also led to easy access to a new family of theranostics, featuring gold, ruthenium and osmium complexes. The compounds’ cytotoxicity was tested on cancer cells, and their cell uptake was followed by fluorescence microscopy in vitro.
- 20 June 2012
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 51 (13) , 7119-7124
Enhancement of Cytotoxicity by Combining Pyrenyl-Dendrimers and Arene Ruthenium Metallacages
Three generations of pyrenyl bis-MPA dendrimers with two different end-groups, acetonide (pyrGn) or alcohol (pyrGn-OH) (n = 1–3), were synthesized, and the pyrenyl group of the dendritic molecules was encapsulated in the arene ruthenium metallacages, [Ru6(p-cymene)6(OO∩OO)3(tpt)2]6+ (OO∩OO = 5,8-dioxydo-1,4-naphtaquinonato (donq) [1]6+ and 6,11-dioxydo-5,12-naphtacenedionato (dotq) [2]6+; tpt =2,4,6-tri(pyridin-4-yl)-1,3,5-triazine). The host–guest properties of [guest⊂1]6+ and [guest⊂2]6+ were studied in solution by NMR and UV–vis spectroscopic methods, thus allowing the determination of the affinity constants. Moreover, the cytotoxicity of these water-soluble host–guest systems and the pyrenyl-dendrimers was evaluated on human ovarian cancer cells.
- 20 June 2012
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 51 (13) , 7119-7124
Enhancement of Cytotoxicity by Combining Pyrenyl-Dendrimers and Arene Ruthenium Metallacages
Three generations of pyrenyl bis-MPA dendrimers with two different end-groups, acetonide (pyrGn) or alcohol (pyrGn-OH) (n = 1–3), were synthesized, and the pyrenyl group of the dendritic molecules was encapsulated in the arene ruthenium metallacages, [Ru6(p-cymene)6(OO∩OO)3(tpt)2]6+ (OO∩OO = 5,8-dioxydo-1,4-naphtaquinonato (donq) [1]6+ and 6,11-dioxydo-5,12-naphtacenedionato (dotq) [2]6+; tpt =2,4,6-tri(pyridin-4-yl)-1,3,5-triazine). The host–guest properties of [guest⊂1]6+ and [guest⊂2]6+ were studied in solution by NMR and UV–vis spectroscopic methods, thus allowing the determination of the affinity constants. Moreover, the cytotoxicity of these water-soluble host–guest systems and the pyrenyl-dendrimers was evaluated on human ovarian cancer cells.
- 16 June 2012
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 17 (6) , 951-960
Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+ (1 X is H, 2 X is Me, 3 X is Ph, 4 X is Br, 5 X is OH, 6 X is NO2, 7 X is OMe, 8 X is CF3, 9 X is F, 10 X is Pr i , 11 X is Bu t ) have been synthesized from the reaction of [(η6-p-MeC6H4Pr i )RuCl2]2 with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(η6-C6H6)2Ru2(SC6H5)3]+ (12) and [(η6-C6Me6)2Ru2(SC6H5)3]+ (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 µM in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants σ p) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters).
- 16 June 2012
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 17 (6) , 951-960
Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential
A series of cationic dinuclear p-cymene ruthenium trithiophenolato complexes of the type [(η6-p-MeC6H4Pr i )2Ru2(SC6H4-p-X)3]+ (1 X is H, 2 X is Me, 3 X is Ph, 4 X is Br, 5 X is OH, 6 X is NO2, 7 X is OMe, 8 X is CF3, 9 X is F, 10 X is Pr i , 11 X is Bu t ) have been synthesized from the reaction of [(η6-p-MeC6H4Pr i )RuCl2]2 with the corresponding thiol, isolated as the chloride salts, and further studied for their electrochemical properties, cytotoxicity towards human ovarian cancer cells, and catalytic activity for glutathione (GSH) oxidation. Complex 1 was also compared with the benzene and hexamethylbenzene analogues [(η6-C6H6)2Ru2(SC6H5)3]+ (12) and [(η6-C6Me6)2Ru2(SC6H5)3]+ (13). The most active compound [11]Cl was structurally studied by single-crystal X-ray diffraction analysis. The concentrations corresponding to 50 % inhibition of cancer cell growth (IC50 values) in the A2780 and A2780cisR cell lines of these complexes except for 6 were in the submicromolar range, complex 11 showing an IC50 value of 0.03 µM in both cell lines. The high in vitro anticancer activity of these complexes may be at least partially due to their catalytic potential for the oxidation of GSH, although there is no clear correlation between the IC50 values and the turnover frequencies at about 50 % conversion. However, the cytotoxicity is tentatively correlated to the physicochemical properties of the compounds determined by the electronic influence of the substituents X (Hammett constants σ p) and the lipophilicity of the thiols p-XC6H4SH (calculated log P parameters).
- 1 April 2012
- Published by Elsevier in Inorganic Chemistry Communications
- Vol. 18, 25-28
Encapsulation of hydrophobic pyrenylcycloplatinate complexes within a water-soluble arene ruthenium metallacage
- 1 April 2012
- Published by Elsevier in Inorganic Chemistry Communications
- Vol. 18, 25-28
Encapsulation of hydrophobic pyrenylcycloplatinate complexes within a water-soluble arene ruthenium metallacage
- 6 March 2012
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 51 (6) , 3633-3639
Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
Anthracene derivatives of ruthenium(II) arene compounds with 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (pta) or a sugar phosphite ligand, viz., 3,5,6-bicyclophosphite-1,2-O-isopropylidene-α-d-glucofuranoside, were prepared in order to evaluate their anticancer properties compared to the parent compounds and to use them as models for intracellular visualization by fluorescence microscopy. Similar IC50 values were obtained in cell proliferation assays, and similar levels of uptake and accumulation were also established. The X-ray structure of [{Ru(η6-C6H5CH2NHCO-anthracene)Cl2(pta)] is also reported.
- 6 March 2012
- Published by American Chemical Society (ACS) in Inorganic Chemistry
- Vol. 51 (6) , 3633-3639
Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds
Anthracene derivatives of ruthenium(II) arene compounds with 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane (pta) or a sugar phosphite ligand, viz., 3,5,6-bicyclophosphite-1,2-O-isopropylidene-α-d-glucofuranoside, were prepared in order to evaluate their anticancer properties compared to the parent compounds and to use them as models for intracellular visualization by fluorescence microscopy. Similar IC50 values were obtained in cell proliferation assays, and similar levels of uptake and accumulation were also established. The X-ray structure of [{Ru(η6-C6H5CH2NHCO-anthracene)Cl2(pta)] is also reported.